Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02787668
What this trial is testing

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

Who this might be right for
Non-alcoholic Fatty Liver DiseaseChildhood ObesityInsulin Resistance
University of Alabama at Birmingham 27
Not applicableUnknownNCT05855239
What this trial is testing

Quantification of Hepatic Steatosis With Different Ultrasound Frequency

Who this might be right for
Fatty LiverFatty Liver, NonalcoholicUltrasound
Jong Keon Jang 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06005012
What this trial is testing

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Who this might be right for
Fibrosis, LiverType 2 Diabetes Mellitus in ObeseNon-Alcoholic Fatty Liver Disease
University of California, San Diego 120
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableActive Not RecruitingNCT05607745
What this trial is testing

Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study

Who this might be right for
NAFLDFecal MicrobiotaGut Microbiota+6 more
University of Eastern Finland 54
Not applicableStudy completedNCT00262964
What this trial is testing

Obesity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Washington University School of Medicine 51
Not applicableStudy completedNCT02728765
What this trial is testing

Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Obstructive Sleep ApneaNon-alcoholic Fatty Liver Disease
Chinese University of Hong Kong 120
Not applicableLooking for participantsNCT05890365
What this trial is testing

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLow Birth Weight
Steno Diabetes Center Copenhagen 300
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Not applicableStudy completedNCT05858138
What this trial is testing

To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Taichung Tzu Chi Hospital 108
Not applicableUnknownNCT06257732
What this trial is testing

Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseFatty Liver, Nonalcoholic+1 more
Yeditepe University 144
Testing effectiveness (Phase 2)Study completedNCT04052516
What this trial is testing

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
NorthSea Therapeutics B.V. 280
Not applicableStudy completedNCT03847116
What this trial is testing

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLight-to-moderate Alcohol ConsumptionType2 Diabetes Mellitus
Ningbo No. 1 Hospital 14,014
Not applicableNot Yet RecruitingNCT06623084
What this trial is testing

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more
Stefania Basili 132
Testing effectiveness (Phase 2)Ended earlyNCT02244944
What this trial is testing

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Gregory Graf, PhD 2
Not applicableStudy completedNCT06275906
What this trial is testing

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Who this might be right for
NAFLDObesityIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 36
Testing effectiveness (Phase 2)Study completedNCT00062764
What this trial is testing

Treating Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Not applicableStudy completedNCT04389593
What this trial is testing

Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisLiver Fibroses+1 more
University of California, San Diego 30
Not applicableStudy completedNCT03447964
What this trial is testing

Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Groupe Hospitalier Pitie-Salpetriere 128
Not applicableWithdrawnNCT05827432
What this trial is testing

FCI Effectiveness in NAFLD Stratification

Who this might be right for
Non-Alcoholic Fatty Liver Disease
NHS Grampian
Next Page